The filing is a routine advance notice of a small sale by a director. No material impact expected; monitor for any subsequent Form 4 filings to confirm execution.
BMY drugs
BMY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $62.14entry
- T+1 · 8d ago 0.00%α −2.37% · $62.14
- T+5 · 4d ago +2.08%α −0.52% · $63.43
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Julia A. Haller filed a Form 144 notice of intent to sell 3,800 shares of Bristol Myers Squibb common stock, with an approximate market value of $250,000. The sale represents a small fraction of her total holdings and the company's $131B market cap, making it a routine insider diversification move.
Key Facts
- Insider: Julia A. Haller, Director
- Shares to be sold: 3,800 shares of common stock
- Approximate value: $250,000
- Date of proposed sale: 11/05/2026
- Shares acquired on 06/13/2021 (stock bonus) and 06/03/2022 (stock bonus)
- Broker: Merrill Lynch
Financial Impact
Sale of 3,800 shares valued at ~$250,000, representing less than 0.0003% of BMY's $131.2B market cap
Risk Factors
- Form 144 is an intent to sell, not a completed transaction; the sale may not occur
- No unusual insider selling pattern detected; this appears to be a routine diversification trade
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-071514 |
| Document: 0001628280-26-071514-index.html | 0001628280-26-071514 |
| Document: 0001628280-26-071514.txt | 0001628280-26-071514 |
Track record
9 reports on BMY
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +6.33% at T+20 after the Aug 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $62.14 to $62.14 Now $62.93 +1.27% · 0.00% −2.37% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $61.39 to $62.48 Now $62.93 +2.51% ▲ +1.78% +3.55% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $61.48 to $61.61 Now $62.93 +2.36% ▲ +0.21% −0.50% vs SPY
- Oct 5, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Aug 17, 202613w ago Institutional Cluster Bullish 6/10 Entry $64.63 to $66.05 Now $62.93 −2.63% ▲ +2.20% +2.87% vs SPY
- Aug 5, 202614w ago ANALYST-UPGRADE Bullish 4/10 Entry $63.63 to $64.15 Now $62.93 −1.10% ▲ +0.82% +0.98% vs SPY
- Jul 30, 202615w ago 8-K Bullish 7/10 Entry $64.86 to $65.31 Now $62.93 −2.98% ▲ +0.69% −0.01% vs SPY
- Mar 25, 202633w ago DEFA14A Neutral 3/10 Entry $59.39 to $58.47 Now $62.93 +5.97% ▼ −1.55% +0.13% vs SPY
- Feb 26, 202637w ago Court Ruling Neutral 3/10 Entry $62.37 to $62.34 Now $62.93 +0.90% ▼ −0.05% −0.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers